Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session



  • CinCor Pharma, Inc. CINC shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
  • Apexigen, Inc. APGN jumped 111% to $1.99 after climbing more than 10% on Friday.
  • Amryt Pharma plc AMYT gained 106.7% to $14.49 after Chiesi Farmaceutici announced it will acquire the company for $14.50 per ADS plus contingent value rights of up to an additional $2.50 per ADS.
  • Albireo Pharma, Inc. ALBO shares climbed 92.9% to $44.03 after Ipsen announced it will acquire the company for $42 per share plus a contingent value right of $10 per share.
  • Duck Creek Technologies, Inc. DCT gained 47% to $19.10 after the company agreed to be acquired by Vista Equity Partners for $2.6 billion.
  • Revance Therapeutics, Inc. RVNC surged 43% to $28.25 as the company reported the FDA acceptance Of supplemental Biologics License Application for DAXXIFY for injection for the treatment of cervical dystonia.
  • Novo Integrated Sciences, Inc. NVOS rose 35.9% to $0.2052. Novo Integrated Sciences recently reported it entered an agreement to purchase 100% of shares of SWAG in exchange for $1.00.
  • Sema4 Holdings Corp. SMFR gained 34% to $0.3299. Sema4 sees preliminary 2022 pro-forma revenues of $170 million to $173 million.
  • Comera Life Sciences Holdings, Inc. CMRA gained 32% to $2.02. Comera Life Sciences 10% owner Charles Cherington bought a total of 743,243 shares at an average price of $1.23.
  • Party City Holdco Inc. PRTY climbed 31.9% to $0.2363. Party City shares dropped 50% on Friday following a report suggesting the company has hired a restructuring advisor and plans a bankruptcy filing within weeks.
  • Bed Bath & Beyond Inc. BBBY rose 30.9% to $1.7150. Bed Bath & Beyond shares dropped over 22% on Friday following a report indicating the company could file for bankruptcy in the coming weeks.
  • CureVac N.V. CVAC shares rose 30.4% to $10.77. CureVac shares jumped over 29% on Friday after the company announced data on joint COVID-19 and flu mRNA vaccine development programs.
  • ZyVersa Therapeutics, Inc. ZVSA jumped 28% to $2.06.
  • Better Choice Company Inc. BTTR gained 28% to $0.7293.
  • Hempacco Co., Inc. HPCO rose 28% to $1.19.
  • Bit Digital, Inc. BTBT gained 28% to $0.9498. Bit Brother regained compliance with Nasdaq minimum bid price requirements for continued listing.
  • Celyad Oncology SA CYAD jumped 25.1% to $0.7482. Celyad Oncology recently reported it has decided to discontinue the development of its remaining clinical program CYAD-211.
  • Paya Holdings Inc. PAYA gained 24.5% to $9.70 after Nuvei entered into a definitive agreement to acquire the company for $9.75 per share in cash.
  • LexinFintech Holdings Ltd. LX jumped 24.5% to $2.9892.
  • Xos, Inc. XOS jumped 23.3% to $1.00.
  • NanoString Technologies, Inc. NSTG surged 23.1% to $9.77. NanoString issued preliminary financial and operational highlights for Q4 and FY 2022.
  • Greenidge Generation Holdings Inc. GREE gained 22.1% to $0.4780.
  • Barfresh Food Group, Inc. BRFH gained 21.1% to $1.49.
  • Grove Collaborative Holdings, Inc. GROV jumped 20.6% to $0.5790.
  • Exact Sciences Corporation EXAS gained 20.5% to $56.85 after the company announced preliminary Q4 results.
  • Tempo Automation Holdings, Inc. TMPO jumped 20% to $1.26.
  • Kronos Bio, Inc. KRON jumped 19.7% to $2.06. Kronos Bio announced discovery collaboration with Genentech to advance novel therapies against transcriptional targets in oncology.
  • Bitfarms Ltd. BITF gained 19.4% to $0.65.
  • Guardion Health Sciences, Inc. GHSI jumped 19.4% to $7.10.
  • Lufax Holding Ltd LU jumped 17.5% to $2.5400.
  • Marathon Digital Holdings, Inc. MARA gained 15.5% to $4.7250. Jefferies downgraded Marathon Digital from Buy to Hold and announced a $4 price target.
  • Coinbase Global, Inc. COIN rose 12.5% to $37.42. Jefferies initiated coverage on Coinbase Global with a Hold rating and announced a price target of $35.
  • Riot Blockchain, Inc. RIOT gained 12% to $4.78. Wells Fargo maintained Riot Platforms with an Equal-Weight and lowered the price target from $6 to $5.
  • Viracta Therapeutics, Inc. VIRX rose 10.3% to $1.81 after the company announced first clinical response in epstein-barr virus-positive (EBV+) solid tumor setting.
  • Zillow Group, Inc. Z gained 8.7% to $39.01 after B of A Securities upgraded the stock from Underperform to Buy and raised its price target from $22 to $42.
  • Tesla, Inc. TSLA jumped 8.3% to $122.44 amid vehicle price cuts in China and indications that wait times for some Chinese Model Y vehicles have increased.
  • Snowflake Inc. SNOW rose 8% to $133.93. Piper Sandler maintained Snowflake with an Overweight and lowered the price target from $200 to $194.


  • Calithera Biosciences, Inc. CALA shares dipped 80.1% to $0.72. Calithera Biosciences announced board approval of complete liquidation and dissolution.
  • MultiMetaVerse Holdings Limited MMV fell 58.4% to $4.81 after jumping 82% on Friday.
  • Moolec Science SA MLEC fell 41.3% to $11.30 after jumping 258% on Friday.
  • Peak Bio, Inc. PKBO dropped 28.8% to $2.5910.
  • Cutera, Inc. CUTR fell 23.4% to $30.97 after the company reported preliminary unaudited financial results for FY22. The company expects to report revenue in the range of $252 million to $253 million for FY22.
  • AMTD Digital Inc. HKD dropped 20.6% to $18.20.
  • Cerus Corporation CERS fell 20.5% to $3.0060. Cerus sees preliminary Q4 product revenues of $44 million, up 10% year over year.
  • Golden Sun Education Group Limited GSUN declined 19.5% to $1.8060.
  • Magic Empire Global Limited MEGL dropped 19.5% to $2.23.
  • Arrowhead Pharmaceuticals, Inc. ARWR fell 18.6% to $30.41. Takeda Pharmaceutical Co and Arrowhead Pharmaceuticals announced topline results from the Phase 2 SEQUOIA study of fazirsiran (TAK-999/ARO-AAT) for liver disease associated with alpha-1 antitrypsin deficiency (AATD-LD).
  • First Wave BioPharma, Inc. FWBI dropped 17% to $0.8720.
  • Monte Rosa Therapeutics, Inc. GLUE declined 17% to $6.57. Monte Rosa Therapeutics outlined progress across portfolio of molecular glue degraders and key anticipated milestones for 2023.
  • Arvinas, Inc. ARVN dropped 15.8% to $28.68. Arvinas said the company and Pfizer have proposed a modification to planned Veritac-3 Phase 3 study.
  • Infobird Co., Ltd IFBD fell 14.8% to $0.7999.
  • Harmony Biosciences Holdings, Inc. HRMY dropped 14.4% to $45.92. Harmony Biosciences named Jeffrey M. Dayno, MD as interim CEO and expands role of Jeff Aronin to executive chairman.
  • BioCryst Pharmaceuticals, Inc. BCRX fell 11.2% to $10.50 after the company reported preliminary FY22 ORLADEYO net revenue results and issued FY23 ORLADEYO net revenue guidance.
  • VYNE Therapeutics Inc. VYNE fell 9.3% to $0.2051 after jumping around 28% on Friday. VYNE Therapeutics, during November, posted a Q3 loss of $0.16 per share.
  • Neptune Wellness Solutions Inc. NEPT fell 8.8% to $0.5901 after jumping around 35% on Friday. Neptune recently announced receipt of NASDAQ notification.
  • Corbus Pharmaceuticals Holdings, Inc. CRBP shares fell 8% to $0.1334 after gaining over 10% on Friday.
  • Macy's, Inc. M fell 7.7% to $20.42 after the company issued Q4 adjusted EPS and sales guidance.

Also Check This Out Bitcoin Tops This Key Level; Gala, Solana Among Top Gainers

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasConsumer DiscretionaryDepartment StoresMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!